Page last updated: 2024-08-23

atracurium and Cardiovascular Diseases

atracurium has been researched along with Cardiovascular Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kummer, O; Mach, F; Marti, G; Roffi, M1
Andrews, EB; Branche, C; Jick, H; Lawson, DH; Pfanschmidt, M; Tilson, HH; Walker, AM1
Andrews, EB; Branche, C; Glavin, RJ; Jick, H; Lawson, DH; Paice, GM; Tilson, H1
Carter, JG; Fehr, BL; Lineberry, CC; Moyers, JR; Shimosato, S; Sokoll, MD1

Other Studies

4 other study(ies) available for atracurium and Cardiovascular Diseases

ArticleYear
[Clopidogrel and its salts: any clnical implication?].
    Revue medicale suisse, 2010, Jun-02, Volume: 6, Issue:251

    Topics: Atracurium; Cardiovascular Diseases; Chloral Hydrate; Clinical Trials as Topic; Clopidogrel; Humans; Hypnotics and Sedatives; Nicotinic Agonists; Platelet Aggregation; Platelet Aggregation Inhibitors; Therapeutic Equivalency; Ticlopidine

2010
Atracurium--a post-marketing surveillance study: methods and U.S. experience.
    British journal of anaesthesia, 1989, Volume: 62, Issue:6

    Topics: Anesthesia Recovery Period; Atracurium; Cardiovascular Diseases; Humans; Intraoperative Complications; Middle Aged; Product Surveillance, Postmarketing; Succinylcholine; United States

1989
Atracurium--a post-marketing surveillance study: U.K. study and discussion.
    British journal of anaesthesia, 1989, Volume: 62, Issue:6

    Topics: Anesthesia Recovery Period; Atracurium; Cardiovascular Diseases; Female; Humans; Intraoperative Complications; Male; Middle Aged; Product Surveillance, Postmarketing; Scotland; United Kingdom

1989
Circulatory effects of atracurium in patients with cardiovascular disease.
    British journal of anaesthesia, 1986, Volume: 58 Suppl 1

    Topics: Anesthesia, General; Atracurium; Cardiovascular Diseases; Hemodynamics; Humans; Isoquinolines; Neuromuscular Blocking Agents; Time Factors

1986